Free Review Articles on Psoriasis                                 Metatextbook

Freie Reviews über Psoriasis                                 Look here for Journal Homepages

  • Psoriasis
  • Adalimumab
  • Efalizumab
  • Arthritis (rheumatoid)
  • Tocilizumab
  • Ustekinumab
  • Infliximab
  • Asthma (BASKET)
  • Alefacept
  • T cell (Th17)
  • Joint (MRT)
  • Hand and wrist (MRT)
  • NK cells
  • Atopic dermatitis
    • Nr.Year

    OPEN

    		Titleusers

    say

    		rate

    good

    		rate

    bad

    no link

    		Citation
    12006Psoriasis and its management.



    		+-nlBMJ 333(7564):380-4 (2006)
    21986Psoriasis.



    		+-nlBr Med J (Clin Res Ed) 292(6537):1693-6 (1986)
    31974Diseases of the skin. Psoriasis.



    		+-nlBr Med J 1(5896):27-9 (1974)
    42005Topical therapies for psoriasis: evidence-based review.



    		+-nlCan Fam Physician 51():519-25 (2005) Afifi T
    52009Psoriasis--new insights into pathogenesis and treatment.



    		+-nlDtsch Arztebl Int 106(1-2):11-8, quiz 19 (2009)
    62009Targeted treatment of psoriasis with adalimumab: a critical appraisal based on a systematic review of the literature.



    		+-nlBiologics 3(-):303-18 (2009)
    72007Efalizumab in the treatment of psoriasis.



    		+-nlBiologics 1(3):301-9 (2007)
    82010Formulary review of 2 new biologic agents: tocilizumab for rheumatoid arthritis and ustekinumab for plaque psoriasis.



    		+-nlJ Manag Care Pharm 16(6):402-16 (2010) Schafer JA
    92004Advancements in the treatment of psoriasis: role of biologic agents.



    		+-nlJ Manag Care Pharm 10(4):318-25 (2004)
    102010Review of ustekinumab, an interleukin-12 and interleukin-23 inhibitor used for the treatment of plaque psoriasis.



    		+-nlTher Clin Risk Manag 6(-):123-41 (2010)
    112006Infliximab (Remicade) in the treatment of psoriatic arthritis.



    		+-nlTher Clin Risk Manag 2(4):389-400 (2006)
    122009Adalimumab for the treatment of psoriasis.



    		+-nlHealth Technol Assess 13 Suppl 2():49-54 (2009) Turner D
    132006Etanercept and efalizumab for the treatment of psoriasis: a systematic review.



    		+-nlHealth Technol Assess 10(46):1-233, i-iv (2006)
    142006Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation.



    		+-nlHealth Technol Assess 10(31):iii-iv, xiii-xvi, 1-239 (2006)
    152000A systematic review of treatments for severe psoriasis.



    		+-nlHealth Technol Assess 4(40):1-125 (2000)
    162010Ustekinumab: an evidence-based review of its effectiveness in the treatment of psoriasis.



    		+-nlCore Evid 5(-):11-22 (2010)
    172007German evidence-based guidelines for the treatment of Psoriasis vulgaris (short version).



    		+-nlArch Dermatol Res 299(3):111-38 (2007)
    182004Alefacept: a novel and selective biologic agent for the treatment of chronic plaque psoriasis.



    		+-nlEur J Dermatol 14(1):41-5 (2004)
    192010Systemic combination treatment for psoriasis: a review.



    		+-nlActa Derm Venereol 90(4):341-9 (2010)
    202002Trends and developments in the pharmacological treatment of psoriasis.



    		+-nlActa Derm Venereol 82(6):401-10 (2002)
    212008T-helper 17 cells in psoriatic plaques and additional genetic links between IL-23 and psoriasis.



    		+-nlJ Invest Dermatol 128(5):1064-7 (2008) Blauvelt A
    222007Mouse models of psoriasis.



    		+-nlJ Invest Dermatol 127(6):1292-308 (2007)
    232007Follow-up analysis of PSORS9 in 151 Chinese families confirmed the linkage to 4q31-32 and refined the evidence to the families of early-onset psoriasis.



    		+-nlJ Invest Dermatol 127(2):312-8 (2007)
    241999Animal models of psoriasis - what can we learn from them?



    		+-nlJ Invest Dermatol 112(4):405-10 (1999)
    252004Immunopathogenic mechanisms in psoriasis.



    		+-nlClin Exp Immunol 135(1):1-8 (2004)
    262002Angiogenesis in psoriasis.



    		+-nlAngiogenesis 5(4):231-6 (2002)
    272009Treatment recommendations for psoriatic arthritis.



    		+-nlAnn Rheum Dis 68(9):1387-94 (2009)
    282006Clinical, radiological, and functional assessment in psoriatic arthritis: is it different from other inflammatory joint diseases?



    		+-nlAnn Rheum Dis 65 Suppl 3(-):iii22-4 (2006)
    292005Psoriatic arthritis imaging: a review of scoring methods.



    		+-nlAnn Rheum Dis 64 Suppl 2():ii61-4 (2005) van der Heijde D
    302005Imaging the joint and enthesis: insights into pathogenesis of psoriatic arthritis.



    		+-nlAnn Rheum Dis 64 Suppl 2(-):ii58-60 (2005)
    312005Psoriatic arthritis and imaging.



    		+-nlAnn Rheum Dis 64 Suppl 2():ii55-7 (2005) Ory PA
    322005Psoriatic arthritis assessment tools in clinical trials.



    		+-nlAnn Rheum Dis 64 Suppl 2(-):ii49-54 (2005)
    332005Psoriasis pathophysiology: current concepts of pathogenesis.



    		+-nlAnn Rheum Dis 64 Suppl 2(-):ii30-6 (2005)
    342005Classification and diagnostic criteria for psoriatic arthritis.



    		+-nlAnn Rheum Dis 64 Suppl 2():ii3-8 (2005) Helliwell PS
    352005Immunopathology of psoriasis and psoriatic arthritis.



    		+-nlAnn Rheum Dis 64 Suppl 2(-):ii26-9 (2005)
    362005Psoriasis: epidemiology, clinical features, and quality of life.



    		+-nlAnn Rheum Dis 64 Suppl 2(-):ii18-23; discussion ii24-5 (2005)
    372005Psoriatic arthritis: epidemiology, clinical features, course, and outcome.



    		+-nlAnn Rheum Dis 64 Suppl 2(-):ii14-7 (2005)
    382005Psoriasis treatment: current and emerging directed therapies.



    		+-nlAnn Rheum Dis 64 Suppl 2(-):ii87-90; discussion ii91-2 (2005)
    392005Psoriasis treatment: traditional therapy.



    		+-nlAnn Rheum Dis 64 Suppl 2(-):ii83-6 (2005)
    402005Psoriatic arthritis treatment: biological response modifiers.



    		+-nlAnn Rheum Dis 64 Suppl 2():ii78-82 (2005) Mease PJ
    412005Psoriatic arthritis therapy: NSAIDs and traditional DMARDs.



    		+-nlAnn Rheum Dis 64 Suppl 2(-):ii74-7 (2005)
    422005Psoriasis assessment tools in clinical trials.



    		+-nlAnn Rheum Dis 64 Suppl 2():ii65-8; discussion ii69-73 (2005) Feldman SR
    431976Psoriatic arthritis. Follow-up study.



    		+-nlAnn Rheum Dis 35(3):206-12 (1976)
    442009Psoriatic arthritis: from pathogenesis to therapy.



    		+-nlArthritis Res Ther 11(1):214 (2009)
    452006Magnetic resonance imaging in psoriatic arthritis: a review of the literature.



    		+-nlArthritis Res Ther 8(2):207 (2006)
    462002Resolution of psoriasis following allogeneic bone marrow transplantation for chronic myelogenous leukemia: case report and review of the literature.



    		+-nlAm J Hematol 71(1):41-4 (2002)
    472007Psoriatic arthritis: current concepts on pathogenesis-oriented therapeutic options.



    		+-nlArthritis Rheum 56(4):1051-66 (2007)
    482004Assessment of patients with psoriatic arthritis: a review of currently available measures.



    		+-nlArthritis Rheum 50(1):24-35 (2004)
    492004Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities.



    		+-nlJ Clin Invest 113(12):1664-75 (2004)
    502007Psoriatic arthritis as a distinct disease entity.



    		+-nlJ Postgrad Med 53(1):63-71 (2007)
    512009New insights into the pathogenesis and genetics of psoriatic arthritis.



    		+-nlNat Clin Pract Rheumatol 5(2):83-91 (2009)
    522003Current concepts and new developments in the treatment of psoriatic arthritis.



    		+-nlRheumatology (Oxford) 42(10):1138-48 (2003)
    532004Psoriasis and the new biologic agents: interrupting a T-AP dance.



    		+-nlCMAJ 170(13):1933-41 (2004) Walsh SR
    542009Progress in understanding the immunopathogenesis of psoriasis.



    		+-nlActas Dermosifiliogr 100 Suppl 2(-):2-13 (2009)
    552008Update on the natural history and systemic treatment of psoriasis.



    		+-nlAdv Dermatol 24(-):171-96 (2008)
    562011Genital psoriasis: A systematic literature review on this hidden skin disease.



    		+-nlActa Derm Venereol 91(1):5-11 (2011)
    572010MRI findings in psoriatic arthritis of the hands.



    		+-nlAJR Am J Roentgenol 195(5):1187-93 (2010)
    582010Effectiveness of adalimumab in treating patients with active psoriatic arthritis and predictors of good clinical responses for arthritis, skin and nail lesions.



    		+-nlAnn Rheum Dis 69(2):394-9 (2010)
    592007Psoriasis--pathophysiology, conventional, and alternative approaches to treatment.



    		+-nlAltern Med Rev 12(4):319-30 (2007)
    602002Clinical features of psoriatic arthritis.



    		+-nlAm J Manag Care 8(6 Suppl):S160-70 (2002)
    612002Current perspectives in the recognition and management of psoriatic arthritis: implications for integrated patient care.



    		+-nlAm J Manag Care 8(6 Suppl):S171-80 (2002)
    622006Psoriatic arthritis update.



    		+-nlBull NYU Hosp Jt Dis 64(1-2):25-31 (2006)
    632010Psoriatic arthritis - update on pathophysiology, assessment, and management.



    		+-nlBull NYU Hosp Jt Dis 68(3):191-8 (2010)
    642011NK cells and psoriasis.



    		+-nlJ Biomed Biotechnol 2011(-):248317 (2011)
    652005Guideline for anti-TNF-alpha therapy in psoriatic arthritis.



    		+-nlRheumatology (Oxford) 44(3):390-7 (2005)
    662007Psoriasis: advances in pathophysiology and management.



    		+-nlPostgrad Med J 83(985):690-7 (2007)
    672005Psoriasis.



    		+-nlN Engl J Med 352(18):1899-912 (2005)
    682011Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis: a systematic review and economic evaluation.



    		+-nlHealth Technol Assess 15(10):i-xxi, 1-329 (2011)
    692009Ustekinumab for the treatment of moderate to severe psoriasis.



    		+-nlHealth Technol Assess 13 Suppl 3(-):61-6 (2009)
    702009Psoriasis (chronic plaque).



    		+-nlClin Evid (Online) 2009(-):- (2009)
    712010Childhood psoriasis.



    		+-nlIndian J Dermatol Venereol Leprol 76(4):357-65 (2010)
    722002Pharmacological interventions for psoriatic arthritis: present and future.



    		+-nlIndian J Dermatol Venereol Leprol 68(4):187-97 (2002)
    732010Novel drug delivery systems in topical treatment of psoriasis: rigors and vigors.



    		+-nlIndian J Dermatol Venereol Leprol 76(6):612-21 (2010)
    742010Psoriasis: what is new in nonbiologic systemic therapy in the era of biologics?



    		+-nlIndian J Dermatol Venereol Leprol 76(6):622-33 (2010)
    752010Newer trends in the management of psoriasis at difficult to treat locations: scalp, palmoplantar disease and nails.



    		+-nlIndian J Dermatol Venereol Leprol 76(6):634-44 (2010)
    762010Management of psoriatic arthritis.



    		+-nlIndian J Dermatol Venereol Leprol 76(6):645-51 (2010)
    772011Current effective topical therapies in the management of psoriasis.



    		+-nlSkin Therapy Lett 16(1):4-7 (2011)
    782010Alefacept treatment for chronic plaque psoriasis.



    		+-nlSkin Therapy Lett 15(4):1-3 (2010)
    792005New developments in topical sequential therapy for psoriasis.



    		+-nlSkin Therapy Lett 10(9):1-4 (2005)
    802008Psoriasis as the marker of underlying systemic disease.



    		+-nlSkin Therapy Lett 13(1):1-5 (2008)
    812008Topical therapy for the management of childhood psoriasis: part I.



    		+-nlSkin Therapy Lett 13(3):1-3 (2008)
    822008The role of the dermatologist in identification and treatment of the early stages of psoriatic arthritis.



    		+-nlSkin Therapy Lett 13(4):4-7 (2008)
    832011Usefulness of ultrasound imaging in detecting psoriatic arthritis of fingers and toes in patients with psoriasis.



    		+-nlClin Dev Immunol 2011(-):390726 (2011)
    842010Post-genomics and skin inflammation.



    		+-nlMediators Inflamm 2010(-):- (2010)
    852010Lipid disturbances in psoriasis: an update.



    		+-nlMediators Inflamm 2010(-):- (2010)
    862008The challenge of early diagnosis of psoriatic arthritis.



    		+-nlJ Rheumatol 35(1):3-5 (2008) Olivieri I

    Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

    All data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.